Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Medacta Group SA    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
11/30/2020 12/01/2020 12/02/2020 12/03/2020 12/04/2020 Date
86.3(c) 87(c) 89.2(c) 88.1(c) 88.7 Last
14 243 13 685 58 982 11 945 2 916 Volume
+1.41% +0.81% +2.53% -1.23% +0.68% Change
More quotes
Financials
Sales 2020 303 M 367 M 367 M
Net income 2020 31,2 M 37,9 M 37,9 M
Net Debt 2020 114 M 138 M 138 M
P/E ratio 2020 56,7x
Yield 2020 0,47%
Sales 2021 360 M 437 M 437 M
Net income 2021 54,4 M 66,1 M 66,1 M
Net Debt 2021 83,7 M 102 M 102 M
P/E ratio 2021 33,0x
Yield 2021 0,79%
Capitalization 1 762 M 1 978 M 2 140 M
EV / Sales 2020 6,20x
EV / Sales 2021 5,13x
Nbr of Employees 1 126
Free-Float 30,7%
More Financials
Company
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee... 
More about the company
Notations Surperformance© of Medacta Group SA
Trading Rating : Investor Rating :
More Ratings
All news about MEDACTA GROUP SA
11/04MEDACTA : proposes the election of Riccardo Braglia as new independent member of..
EQ
10/19MEDACTA : Expands its Knee Offerings with New SensiTiN System with Low Metal Ion..
EQ
10/13MEDACTA : Launches M.U.S.T. 2.0 Instrumentation to Expand its Offerings for Spin..
EQ
09/29MEDACTA : Expands its Knee Portfolio with 3DMetal Femoral Cones for Knee Revisio..
EQ
09/15MEDACTA : Expands its Partial Knee Replacement Solutions with MOTO Lateral Parti..
EQ
09/07MEDACTA : Publication of 2020 Half Year Results
EQ
09/04MEDACTA : Announces Successful Completion of the First Australian Surgery with N..
EQ
09/02MEDACTA : Receives FDA Clearance for the Lateralized Glenosphere
EQ
07/22MEDACTA : Half-year 2020 revenue equal to Euro 135M, down 11.1% over the prior y..
EQ
07/13MEDACTA TO INTRODUCE NEXTAR(TM) : First FDA-Cleared Augmented Reality-Based Surg..
EQ
06/30MEDACTA : Announces First Hip Replacement Surgeries with New Quadra-P System
EQ
06/03MEDACTA : Receives CE Marking for its Long Diaphysis and Stemless Metaphysis Imp..
EQ
05/28MEDACTA : Announces First Surgery Utilizing Mecta-C Stand Alone Anterior Cervica..
EQ
05/26MEDACTA : Announces CE Marking for Multiple Sports Medicine Products and First S..
EQ
05/19MEDACTA : announces the results of today's Annual General Meeting
EQ
More news
News in other languages on MEDACTA GROUP SA
11/04Bourse Zurich: le SMI repasse les 10'200 points et accroche les 10'300
11/04Bourse Zurich: le SMI à la (re)conquête des 10'200 points
11/04Principales informations avant-Bourse
11/04Morning Briefing - Markt Schweiz
11/04Medacta propose d'élire le patron de Helsinn à son conseil d'administration
More news
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 77,35 €
Last Close Price 88,10 €
Spread / Highest target 3,85%
Spread / Average Target -12,2%
Spread / Lowest Target -33,9%
EPS Revisions
Managers
NameTitle
Francesco Siccardi Chief Executive Officer
Alberto Siccardi Executive Chairman
Corrado Farsetta Chief Financial Officer
Maria Luisa Siccardi Tonolli Non-Executive Director
Victor Waldemar Balli Lead Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDACTA GROUP SA23.20%1 991
ABBOTT LABORATORIES24.51%191 681
MEDTRONIC PLC0.13%152 346
BECTON, DICKINSON AND COMPANY-11.07%70 150
HOYA CORPORATION24.59%48 552
ALIGN TECHNOLOGY, INC.81.15%39 857